SEC Form 4 · accession 0000899243-16-019287
Aldeyra Therapeutics, Inc. · ALDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Todd C Brady
Officer — President and CEO · Director
Period of report
May 3, 2016
Accepted (ET)
May 5, 2016 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001341235
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 3, 2016 | A | 27,096 | $0.00 | A | 42,185 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock underlying a restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on May 3, 2017, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.